This project deals with the interactions between EBV-infected cells and the host immune system in normal and immunodefective persons. For an improved understanding of this complex system, it is necessary to broaden our knowledge both on the interaction of the virus with different host cells in vitro and in vivo, and on the interplay between the virally infected cells and the host. This project aims at the analysis of certain questions at both levels, in a mutually interrelated way. The project consists of the following parts: I.Immune responses to EBV and EBV-carrying cells in vitro and in an experimental animal model. II.Virus-cell-host interactions in vivo under normal and pathological conditions. III.Clinically related studies. Part I will deal with the activation of the cellular responses in autologous and allogeneic systems, identification of the EBV-specific rejection targets, experiments to verify or falsify our hypotheses of discriminatory T-cell recognition of different growth transformation associated EBV-proteins, and the study of phenotype dependent differences in B-cell sensitivity to immune rejection. Part II will deal with the presence and expression of EBV genomes in different B-cell subpopulations in vivo, and the evolution of EBV-related malignant epithelial and B-cell phenotypes. Part III will study humoral and cellular responses to virally encoded antigens in healthy seropositives, mononucleosis patients and immunodefectives, viral population exchange in bone marrow transplant patients, EBV-carrying immunoblastic proliferations in immunodefectives, the role of EBV in subfractions of virus carrying chronic lymphocytic leukemia cells, and the role of EBV in nasopharyngeal carcinoma.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA030264-10
Application #
3169162
Study Section
Experimental Immunology Study Section (EI)
Project Start
1981-09-01
Project End
1994-02-28
Budget Start
1991-03-26
Budget End
1992-02-29
Support Year
10
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Karolinska Institute
Department
Type
DUNS #
350582235
City
Stockholm
State
Country
Sweden
Zip Code
171 7-7
Contreras-Brodin, B; Karlsson, A; Nilsson, T et al. (1996) B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter. J Gen Virol 77 ( Pt 6):1159-62
Chen, F; Hu, L F; Ernberg, I et al. (1995) Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas. J Gen Virol 76 ( Pt 1):131-8
Stuber, G; Dillner, J; Modrow, S et al. (1995) HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1. Int Immunol 7:653-63
Lewin, N; Avila-Carino, J; Minarovits, J et al. (1995) Detection of two Epstein-Barr-virus (EBV)-carrying leukemic cell clones in a patient with chronic lymphocytic leukemia (CLL). Int J Cancer 61:159-64
Hu, L F; Chen, F; Zhen, Q F et al. (1995) Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. Eur J Cancer 31A:658-60
Trivedi, P; Zhang, Q J; Chen, F et al. (1995) Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma. Oncogene 11:505-10
Chen, F; Zou, J Z; di Renzo, L et al. (1995) A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol 69:3752-8
Zheng, X; Hu, L; Chen, F et al. (1994) Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol 30B:290-5
Moss, D J; Burrows, S R; Suhrbier, A et al. (1994) Potential antigenic targets on Epstein-Barr virus-associated tumours and the host response. Ciba Found Symp 187:4-13;discussion 13-20
de Campos-Lima, P O; Levitsky, V; Brooks, J et al. (1994) T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J Exp Med 179:1297-305

Showing the most recent 10 out of 87 publications